Search results
Results from the WOW.Com Content Network
The bad news: Its stock was down more than 10% in early trading, largely because of weaker-than-expected 2025 guidance. Merck reported $64.2 billion in sales for 2024, a 7% increase compared with ...
On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...
On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...
On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension (PAH, WHO Group 1 ...
Merck expects full-year 2021 adjusted earnings to be in a range of $5.65 to $5.70 per share versus the estimate of $5.77 per share. The company expects full-year 2021 Why Merck Shares Are Making ...
On Monday, Merck & Co Inc (NYSE:MRK) announced the notice of the mutual exercise of an option to convert the companies’ ongoing co-development and co-commercialization agreement for opevesostat ...
Merck's semiconductor solutions business, which makes up 69% of its electronics business, the smallest of its three divisions that accounts for about 18% of group sales, posted a 10.4% rise in ...
Merck (MRK) might move higher on growing optimism about its earnings prospects, ... News. 24/7 help. For premium support please call: 800-290-4726 more ways to reach us. Login / Join.